Toward the synthesis of the hypoxia selective anticancer agent BE-43547 A2

Abstract
A short and enantioselective synthesis of 19-epi-BE-43547 A2 chiral framework has been achieved in high yield. The challenging key C15 tertiary stereocenter was derived from D-glucose. The synthetic strategy involves a Julia-Kocienski olefination to install the lipophilic side chain. Efficient protocol for Z to E isomerization of olefin was developed using novel UV flow reactor. In addition, an unprecedented oxygen mediated hydroboration, as well as Krapcho de-carboxylation of β-keto lactone were observed.
Funding Information
  • University Grants Commission